Levamisole-induced adverse reactions and histocompatibility testing in malignant melanoma.
D000380:Agranulocytosis / Q000139:chemically induced; D006650:Histocompatibility Testing; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D007978:Levamisole / Q000009:adverse effects* / Q000627:therapeutic use; D008545:Melanoma / Q000188:drug therapy / Q000276:immunology*; D012216:Rheumatic Diseases / Q000139:chemically induced / Q000276:immunology
D007978:Levamisole